immunology enews

Bio-Techne Newsletter | April 3, 2018

 

 

 

4¿ù Immunology Newsletter ¼Ò½Ä

CAR-T cell immunotherapy poster

Immuno-oncologye brochure

-  TLR ¿¬±¸¸¦ À§ÇÑ ´Ù¾çÇÑ small moleculeµé

 

 

 

 

 

chimeric antigen receptor poster

 

New Poster: Chimeric Antigen Receptor-T Cell Immunotherapy
Novus Biologicals
¿¡¼­ CARÀÇ ±¸Á¶ ¹× generation, CAR-T cell¿¡ ÀÇÇÑ tumor cell killing, Â÷¼¼´ë CAR ¹× cancer immunotherapyÀÇ ·£µå¸¶Å© °³¹ß¿¡ ´ëÇÑ °³¿ä¸¦ Æ÷½ºÅä ÇüÅ·ΠÁ¦°øÇÕ´Ï´Ù. Request the poster!

 

immuno-oncology research brochure

 

Explore Our Collection of Products for Immuno-Oncology Research
»õ·Î¿î immune checkpoint regulatorµéÀº cancer immunotherapyÀÇ ÀáÀçÀû Â÷¼¼´ë Ç¥ÀûÀ¸·Î °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. R&D Systems¿¡¼­´Â immuno-oncology target ¿¬±¸¸¦ À§ÇÑ ´Ù¾çÇÑ Á¦Ç°µéÀ» Á¦°øÇÕ´Ï´Ù. Áö±Ý brochure¸¦ È®ÀÎÇØ º¸¼¼¿ä!

 

af1397 neutralization

 

R&D Systems® Immune Checkpoint Blocking Antibodies
Co-targeting multiple immune checkpoint molecules
Àº cancer immunotherapyÀÇ È¿°ú¸¦ Çâ»ó½Ãŵ´Ï´Ù. ¸¸Á·½º·¯¿î ½ÇÇè °á°ú¸¦ À§ÇØ, R&D immune checkpoint targetÀÇ blocking antibody¸¦ È°¿ëÇغ¸¼¼¿ä! Learn more!

 

Dengue Virus

 

Target TLRs with Tocris
Toll-like receptors (TLRs)Àº innate immune system¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Tocris´Â TLR subtypeº° ´Ù¾çÇÑ small molecule ¹× peptide activator/inhibitorµéÀ» Á¦°øÇÕ´Ï´Ù. Áö±Ý È®ÀÎÇØ º¸¼¼¿ä!

 

9229-VS

 

VSIG Proteins: Potential Next Generation Immuno-Oncology Targets?
VSIG9/TIGIT
¿Í VSIG4´Â ¸é¿ª ¾ïÁ¦ ¼ºÁúÀ» °®´Â V-Set and Immunoglobulin domain-containing (VSIG) protein familyÀÔ´Ï´Ù. R&D ÀÚü ½ÇÇè °á°ú, VSIG¿¡ ¼ÓÇÏ´Â ´Ù¸¥ ´Ü¹éÁúµéµµ ºñ½ÁÇÑ È¿°ú¸¦ º¸ÀÌ´Â °ÍÀ¸·Î È®ÀÎ µÆ½À´Ï´Ù. Áö±Ý ¹Ù·Î È®ÀÎÇØ º¸¼¼¿ä!See the data!

 

Butyrophilin and Butyrophilin-like Proteins

 

Butyrophilin and Butyrophilin-like Proteins: B7-related Modulators of T Cell Function
R&D systems
¿¡¼­ butyrophilin (BTN)°ú butyrophilin-like (BTNL) proteinÀÎ BTN3A2, BTNL3, BTNL8, BTNL9ÀÌT cell activity¿¡ ¹ÌÄ¡´Â È¿°ú¸¦ Á¶»çÇÏ°í Æ÷½ºÅÍ·Î Á¦ÀÛÇß½À´Ï´Ù. See the results!

 

dr walcheck

 

Webinar: Engineering iPSC-derived NK Cells for Enhanced Efficacy of Cancer Therapies Now Available on Demand
3
¿ù 21ÀÏ, Dr. Bruce Walcheck °¡ ¹ßÇ¥ÇÏ´Â webinar¸¦ °³ÃÖÇÕ´Ï´Ù. ÁÖÁ¦´Â Engineering iPSC-derived NK Cells for Enhanced Efficacy of Cancer TherapiesÀÔ´Ï´Ù. Webinar ½ÅûÀ» ¿øÇÏ½Ç °æ¿ì µî·ÏÇØÁÖ¼¼¿ä. here!

 

Bio-Techne at Upcoming Meetings

 

2018 Keystone: Organs- and Tissues-on-a-Chip
Big Sky, MT, April 8-12, 2018

 

2018 American Association for Cancer Research
Chicago, IL, April 14-18, 2018

 

2018 Experimental Biology
San Diego, CA, April 21-25, 2018

 

British Society for Gene and Cell Therapy
London, UK, April 27, 2018

 

Immunology 2018¢â
Austin, TX, May 4-8, 2018

 

World Advanced Therapies and Regenerative Medicine 2018
London, UK, May 16-18, 2018

 

International Congress of Autoimmunity 2018
Lisbon, Portugal, May 16-20, 2018

 

View All New Products

 

Have a product suggestion? Let us know here!

 


Á¦Ç° »ó´ã : Çмú¸¶ÄÉÆÃÆÀ ÇѼҿµ (techserv@woongbee.com / 02-881-5432 ³»¼± 731)


¿õºñ¸ÞµðÅØ Assay Service ȨÆäÀÌÁö!! CLICK~CLICK!!

³Ê¹« ¹Ù»Ûµ¥ ºÐ¼® Àåºñ±îÁö?!!! ¿õºñ¸ÞµðÅØ¿¡ ¸Ã±â°í ½ÇÇ轺Ʈ·¹½º¿¡¼­ ÇعæµÇ¼¼¿ä!!

»çÀÌÆ®¸í :(ÁÖ)¿õºñ¸ÞµðÅØ / »óÈ£:(ÁÖ)¿õºñ¸ÞµðÅØ
ÀüÈ­: 02-881-5432 / FAX: 02-881-5454
¼­¿ïƯº°½Ã ¼ÛÆı¸ ¼ÛÆÄ´ë·Î201µ¿ Å׶óŸ¿öAµ¿ 1113È£ (¹®Á¤µ¿642¹øÁö)
Copyright¨ÏAll Rights Reserved Any questions to woongbee@woongbee.com

-2018³â 04¿ù 09ÀÏ-